
Browsing restrictions can be lifted for a fee.
Taiwan Styrene Monomer Corporation, together with its subsidiaries, produces and sells styrene monomer, para-diethyl benzene, toluene, methyl benzene, hydrogen, and ethyl benzene in Taiwan, the United States, and internationally. The company operates in three segments: Plastic, Investment, and Other. Its products are used in electrical appliances, machines, electronics, automobile, packaging, and other industries. The company primarily serves the manufacturers of polystyrene, acrylonitrile-butadiene-styrene resins, and synthetic rubber. It also offers medical equipment wholesale, and piping engineering services. In addition, the company provides residential building and industrial plant development rental services; hotels; manufactures chemical and plastic raw materials; manufactures electric components; and offers educational, information, software, and data storage consulting services. Taiwan Styrene Monomer Corporation was incorporated in 1979 and is headquartered in Taipei City, Taiwan.
1310
台苯
9.02%
(0.09)
The most recent financial report for 台苯 (1310) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1310's short-term business performance and financial health. For the latest updates on 1310's earnings releases, visit this page regularly.
According to the latest financial report, 台苯 (1310) reported an Operating Profit of -163.42M with an Operating Margin of -7.36% this period, representing a growth of 18.69% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 台苯 (1310) announced revenue of 2.22B, with a Year-Over-Year growth rate of -26.8%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 台苯 (1310) held Total Cash and Cash Equivalents of 602.79M, accounting for 0.06 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 台苯 (1310) did not achieve the “three margins increasing” benchmark, with a gross margin of -5.28%%, operating margin of -7.36%%, and net margin of -5.64%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1310's profit trajectory and future growth potential.
According to the past four quarterly reports, 台苯 (1310)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.24. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
台苯 (1310)'s Free Cash Flow (FCF) for the period is 19.66M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 72.76% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.